Vlaams Instituut Voor Biotechnologie - Flanders Institute

Vlaams Instituut Voor Biotechnologie - Flanders Institute

Vlaams Instituut Voor Biotechnologie - Flanders Institute

Overview
Date Founded

1995

Headquarters

Rijvisschestraat 120,Ghent, Flemish Region 9052

Company Description

Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium.

Executives & Employees

Chief Financial Officer

Vice Chairman

Managing Director

Co-Managing Director

Director-Human Resources

Professor of Molecular Medicine

Manager-Business Development

Scientist, Peter Carmeliet Lab

Board of Directors

Board of Trustees-Term Trustees at Carnegie Mellon University

Vice Chairman at Vlaams Instituut Voor Biotechnologie - Flanders Institute

Former Chief Financial Officer & Director at deVGen NV

Managing Director at Viziphar Biosciences BVBA

Chairman, Chief Executive Officer & Head-Investor Relations at ERYTECH Pharma SA

Founder at PGS International NV

Professor at Catholic University of Louvain

Delegate Manager at Bayer Bioscience NV

Professor at KU Leuven Research & Development

Coordinator-Strategic Research at University of Antwerp

Distinguished Alumni
Hugo M. Levecke is now Former Mitglied des Vorstands at T Group AG
Paths to Vlaams Instituut Voor Biotechnologie - Flanders Institute
Potential Connections via
Relationship Science
You
Vlaams Instituut Voor Biotechnologie - Flanders Institute
Clients

Oxurion NV is a biopharmaceutical company, which engages in developing and commercializing medicines for the treatment of vitreo retinal diseases. It operates under JETREA (ocriplasmin) brand name. The company was founded by Desire Collen in 1991 and is headquartered in Leuven, Belgium.

Denali Therapeutics, Inc. engages in the development of portfolio of therapeutic candidates for neurodegenerative diseases. Its programs comprises of lysosomal function pathway, glial biology pathway, and cellular homeostasis. The company was founded by Ryan J. Watts, Marc Tessier-Lavigne, and Alexander Schuth in 2013 and is headquartered in San Francisco, CA.

IMV, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of cancer immunotherapies and infectious disease vaccines. The firm's patented platform, DepoVax, provides controlled and prolonged exposure of antigens and adjuvant to the immune system. The company was founded by Warwick Kimmins and Brian Lowe on March 28, 2000 and is headquartered in Halifax, Canada.

Investments
Details Hidden

AlgoNomics NV provided integrated immunogenicity services for the biopharmaceutical industry. The company's products included Epibase, Epibase-IV, and Tripole. It was founded by Philippe Stas and Ignace Lasters in 1999 and was headquartered in Gent, Belgium.

Details Hidden

Aelin Therapeutics NV is a company headquartered in Leuven, Belgium. The firm develops drugs for antibiotics and first-in-class therapeutics. It was founded in 2017.

Details Hidden

Aphea.bio SA engages in research and development of biotechnology and agricultural products. It develops next generation biopesticides and biostimulants based on natural microorganisms. The company was founded by Isabel Vercauteren and Steven Vandenabeele in December 5, 2016 and is headquartered in Ghent, Belgium.